Literature DB >> 8299944

Novel lacZ-based recombination vectors for mammalian cells.

L B Herzing1, M S Meyn.   

Abstract

We have constructed two sets of Escherichia coli lacZ-based vectors for use in studies of general mitotic recombination, both in somatic mammalian cells grown in culture and in transgenic animals. The vectors use two mutant copies of the E. coli lacZ gene as their recombination substrates and contain a neo gene for selection of stable transformants. In one vector, pLrec, an SV40 promoter drives lacZ, while the other vector, pArec, utilizes a human non-muscle beta-actin promoter for lacZ expression. Gene conversions, unequal sister chromatid exchanges and reciprocal exchanges between the two lacZ genes result in expression of beta-galactosidase, which can be detected in situ by histochemical staining. These vectors yield rates and frequencies of mitotic intrachromosomal recombination in human and rodent cell lines which are similar to rates reported using conventional recombination vectors. Molecular analysis of recombinational events involving the lacZ-based vectors can be carried out on genomic DNA isolated from clonally expanded populations and individual LacZ+ cells and cell clusters can be analyzed using PCR amplification. These reporter gene-based vectors may facilitate the study of recombination in cells with limited proliferative capacities, allow for analysis of both products of an unequal sister chromatid exchange, and permit in situ detection of recombination in the tissues of transgenic animals.

Entities:  

Mesh:

Year:  1993        PMID: 8299944     DOI: 10.1016/0378-1119(93)90002-k

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

Review 1.  Reporter gene vectors and assays.

Authors:  E Schenborn; D Groskreutz
Journal:  Mol Biotechnol       Date:  1999-11       Impact factor: 2.695

2.  Determination of the frequency of retroviral recombination between two identical sequences within a provirus.

Authors:  T Li; J Zhang
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Genetic analysis of the Chlamydomonas reinhardtii I-CreI mobile intron homing system in Escherichia coli.

Authors:  L M Seligman; K M Stephens; J H Savage; R J Monnat
Journal:  Genetics       Date:  1997-12       Impact factor: 4.562

4.  Extrachromosomal recombination occurs efficiently in cells defective in various DNA repair systems.

Authors:  C Morrison; E Wagner
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

5.  Loss of Werner syndrome protein function promotes aberrant mitotic recombination.

Authors:  P R Prince; M J Emond; R J Monnat
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

6.  Efficient in situ electroporation of mammalian cells grown on microporous membranes.

Authors:  T A Yang; W C Heiser; J M Sedivy
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

7.  Inhibition of poly(ADP-ribose)polymerase does not affect the recombination events in CHO xrs6 and wild type cells.

Authors:  Maria Wojewódzka; Marcin Kruszewski; Tomasz Ołdak; Teresa Bartłomiejczyk; Aneta Goździk; Irena Szumiel
Journal:  Radiat Environ Biophys       Date:  2006-09-12       Impact factor: 1.925

8.  Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation.

Authors:  S Vispé; C Cazaux; C Lesca; M Defais
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

9.  RNA interference inhibition of Mus81 reduces mitotic recombination in human cells.

Authors:  Veronique Blais; Hui Gao; Cherilyn A Elwell; Michael N Boddy; Pierre-Henri L Gaillard; Paul Russell; Clare H McGowan
Journal:  Mol Biol Cell       Date:  2003-11-14       Impact factor: 4.138

10.  Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins.

Authors:  S Li; P Janosch; M Tanji; G C Rosenfeld; J C Waymire; H Mischak; W Kolch; J M Sedivy
Journal:  EMBO J       Date:  1995-02-15       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.